Our team
At the core of Sutura's innovative approach are its people. Each member brings a unique blend of skill, passion and perspective to the team.
As People & Culture Manager, Jo supports Sutura achieve its objectives through developing and implementing People plans/ initiatives.
More ►
Wouter conducts in vitro/in vivo studies and assays for lead optimisation and contributes to our drug conjugate platform development, research, planning, and scientific decisions.
More ►
Liesbeth oversees both research and development and CMC at Sutura. She brings in-depth experience and comprehensive knowledge of developing and producing cutting-edge therapies to the company.
More ►
Amar leads the In-Vivo section of Sutura, generating essential pre-clinical data for our drug conjugate platform development and collaborates with CROs for efficient clinical progression.
More ►
Tatiana performs experiments in support of Sutura’s research projects. Her duties include techniques in molecular, cell biology and immunohistochemistry for functional and target validation.
More ►
Mavra has extensive experience in peptide manufacturing, specialising in Solid-Phase Peptide Synthesis (SPPS). Her role focuses on synthesising peptides for the development and optimisation of our drug conjugate platform.
More ►
Thanuja plans and executes in vitro studies and design assays to understand the drug conjugate mode of action. As part of the R&D team, she also supports the lead optimisation programmes.
More ►
Jolande contributes 20 years of expertise in clinical development and programme management to her position at Sutura Therapeutics.
More ►
As Sutura’s CEO, Edwin draws upon his extensive experience in the translation and commercial development of innovative therapies, which includes specialised knowledge in advanced therapy medicinal products (ATMPs) and orphan drugs.
More ►
Ashley brings two decades’ worth of translational research experience and a passion for peptide chemistry to his role as Associate Director, CMC, at Sutura Therapeutics.
More ►
